Cerebral blood flow and metabolism in fulminant liver failure
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Fulminant liver failure is a syndrome that is frequently complicated by cerebral edema and increased intracranial pressure. Cerebral blood flow has been reported as high in some studies but low in others. This study undertook to measure cerebral blood flow and cerebral metabolic rate for oxygen in 30 patients with fulminant liver failure in grade 4 encephalopathy and to assess these parameters after intervention with hyperventilation and infusions of mannitol, epoprostenol and acetylcysteine. Cerebral blood flow varied widely, from 14 to 71 ml/100 gm/min (normal range, 41 to 66), whereas the cerebral metabolic rate for oxygen was low in all patients, 0.16 to 2.03 ml/100 gm/min (normal range, 3.12 to 3.96). Twenty-one of the 30 patients had evidence of anaerobic metabolism with cerebral lactate production. Hyperventilation resulted in a significant decrease in both cerebral blood flow (median, 36 to 28 ml/100 gm/min) and cerebral metabolic rate for oxygen (median, 0.92 to 0.65 ml/100 gm/min); mannitol and acetylcysteine infusions resulted in significant increases in both of these parameters. Prostaglandin I 2 infusion did not significantly alter cerebral blood flow, but there was a significant increase in cerebral metabolic rate for oxygen. The depressed cerebral metabolic rate for oxygen in patients with fulminant liver failure is inappropriate to metabolic requirements, as demonstrated by both cerebral lactate production and the increase in cerebral oxygen consumption after improvement in cerebral blood flow. Mannitol infusion should remain the main treatment of the cerebral complications of fulminant liver failure. Acetylcysteine has a beneficial effect that is not restricted to fulminant liver failure after acetaminophen overdose and has a role in the management of patients, regardless of cause of illness. The use of prostaglandin I 2 appears to be safe and may be beneficial. Acute hyperventilation causes decreases in both cerebral blood flow and cerebral metabolic rate for oxygen and has the potential to worsen cerebral ischemia. (Hepatology 1994;19:1407-1413.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These effects include non-specific antioxidant effects, preservation of cerebral blood flow and perfusion in cerebral edema after liver failure (224).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [224]
Citations
Cites
Greenberg, H. B. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170210085033 · Cited by 848
The management of fulminant hepatic failure.
Trey, C., & Davidson, C. S. (1970) · PubMed · Cited by 642
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585 · cited 3×
“Infusions of prostaglandin I, (PGI,) and acetylcysteine were also investigated because they have been shown to effectively reverse systemic oxygen debt in FLF (8).”
BackgroundSelf-citationBihari, D., Smithies, M., Gimson, A., & Tinker, J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170701 · Cited by 554
Powers, W. J., Grubb, R. L., Darriet, D., & Raichle, M. E. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.89 · Cited by 425
Muizelaar, J. P., Marmarou, A., DeSalles, A. A. F., Ward, J. D., Zimmerman, R. S., Li, Z., Choi, S. C., & Young, H. F. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.1.0063 · Cited by 331
Cerebral Edema: A Major Complication of Massive Hepatic Necrosis
Ware, A. J., D’Agostino, A. N., & Combes, B. (1971) · Gastroenterology · doi:10.1016/s0016-5085(19)33402-x · Cited by 267
SULFHYDRYL REQUIREMENT FOR RELAXATION OF VASCULAR SMOOTH MUSCLE
Needleman, P., Jakschik, B., & Johnson, E. M. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29678-1 · Cited by 250
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
Stamler, J., Mendelsohn, M. E., Amarante, P., Smick, D., Andon, N., Davies, P. F., Cooke, J. P., & Loscalzo, J. (1989) · Circulation Research · doi:10.1161/01.res.65.3.789 · Cited by 244
Wei, E. P., Kontos, H. A., Christman, C. W., DeWitt, D. S., & Povlishock, J. T. (1985) · Circulation Research · doi:10.1161/01.res.57.5.781 · Cited by 202
Research works printed but not linked: 5
- Kramer, 1991, Transplant Proc, 23, 1895
- Robin, 1980, Am Rev Respir Dis, 122, 517
- Needleman, 1973, J Pharmacol Exp Ther, 187, 324
- Berk, 1978, Am J Gastroenterol, 69, 349
- Keays, 1991, Q J Med, 79, 425
Cited by
Items 101–200 of 220
Treatment of hepatic failure—1996: Current concepts and progress toward liver dialysis
Sussman, N., & Lake, J. R. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90094-3 · Cited by 27
Management of hepatic encephalopathy in children
Arya, R., Gulati, S., & Deopujari, S. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.079467 · Cited by 23
“Epoprostenol (prostaglandin I2) has also been shown to improve the cerebral metabolic rate for oxygen.(37)”
BackgroundCerebral Blood Flow in Hyperammonemia: Heterogeneity and Starling Forces in Capillaries
Larsen, F. S. (2002) · Metabolic Brain Disease · doi:10.1023/a:1021941414605 · Cited by 24
“This view is also, at least to some extent, supported by other experimental (Chung et al., 2001; Larsen et al., 2001) and clinical studies (Durham et al., 1995; Wendon et al., 1994 ) demonstrating that cerebral vasodilatation is associated with high intracranial pressure and cerebral herniation in hyperammonemia.”
ResultAstrocytes and Ammonia in Hepatic Encephalopathy
Norenberg, M. D. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-105-3_26 · Cited by 24
PREVENTION AND TREATMENT OF DRUG-INDUCED LIVER DISEASE
Speeg, K. V., & Bay, M. K. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00240-5 · Cited by 22
Acute Liver Failure in Children
Sabapathy, D. G., & Desai, M. S. (2022) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2022.02.003 · Cited by 22
Strauss, G. I. (2007) · PubMed · Cited by 22
Liver failure, transplantation, and critical care
Krasko, A., Deshpande, K. S., & Bonvino, S. (2003) · Critical Care Clinics · doi:10.1016/s0749-0704(02)00051-9 · Cited by 24
Critical care management of patients before liver transplantation
Ford, R. M., Sakaria, S. S., & Subramanian, R. (2010) · Transplantation Reviews · doi:10.1016/j.trre.2010.05.003 · Cited by 21
“As mentioned previously, hyperventilation is not indicated [45,65].”
BackgroundArdizzone, G., Arrigo, A., Panaro, F., Ornis, S., Colombi, R., Distefano, S., Jarzembowski, T. M., & Cerruti, E. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.11.014 · Cited by 21
Bioenergetic dysfunction in a zebrafish model of acute hyperammonemic decompensation
Zielonka, M., Probst, J., Carl, M., Hoffmann, G. F., Kölker, S., & Okun, J. G. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.008 · Cited by 22
Eisen, J. S., Koren, G., Juurlink, D. N., & Ng, V. L. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120028751 · Cited by 21
Acute Liver Failure: Current Practice and Recent Advances
Sundaram, V., & Shaikh, O. S. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2011.06.009 · Cited by 20
Hypothermia for the Management of Intracranial Hypertension in Acute Liver Failure
Jalan, R., Davies, N. A., & Damink, S. W. M. O. (2002) · Metabolic Brain Disease · doi:10.1023/a:1021930506853 · Cited by 18
Acute changes in cerebral blood flow and metabolism during portasystemic shunting
Jalan, R., Newby, D. E., Damink, S. W. M. O., Redhead, D. N., Hayes, P. C., & Lee, A. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.22181 · Cited by 17
Cerebral hemodynamic and metabolic changes in fulminant hepatic failure
Paschoal, F. M., Nogueira, R. D. C., Oliveira, M. D. L., Paschoal, E. H. A., Teixeira, M. J., D′Albuquerque, L. A. C., & Bor‐Seng‐Shu, E. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170076 · Cited by 17
Structured approach to treat patients with acute liver failure: A hepatic emergency
Bhatia, V., & Kumar, R. K. (2012) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.94409 · Cited by 17
“[18] Acute hyperventilation is recommended only as emergency rescue therapy of patients with evidence of brain herniation, because hypocapnia-induced cerebral vasoconstriction decreases ICP.”
BackgroundInfluentialSaraswat, V. A., Saksena, S., Nath, K., Mandal, P. K., Singh, J., Thomas, M. A., Rathore, R. S., & Gupta, R. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4168 · Cited by 16
“The cerebral blood flow is an important hemodynamic parameter that is shown to be reduced after mannitol administration[ 46 ,47].”
BackgroundAsymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
Czarnecka, A. M., Milewski, K., & Zielińska, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2111-x · Cited by 16
“A study in 30 patients in various stages of HE suggested that the CBF was likely to be low [63].”
BackgroundHypothermia for the management of intracranial hypertension in acute liver failure
Jalan, R., & Damink, S. W. M. O. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200108000-00008 · Cited by 15
Lessons on brain edema in HE: from cellular to animal models and clinical studies
Pierzchała, K., Hadjihambi, A., Mosso, J., Jalan, R., Rose, C. F., & Cudalbu, C. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01269-5 · Cited by 17
“…subsequent studies went on to show the importance of alterations in cerebral blood flow (CBF) (both hyperemia and ischemia) (Jalan et al. 2004; Wendon et al. 1994), systemic and neuroinflammation (Rolando et al. 2000) and, evidence that in the sickest patients with ALF with uncontrolled…”
BackgroundED utilization of computed tomography in a poisoned population
Patel, M. M., Tsutaoka, B. T., Banerji, S., Blanc, P. D., & Olson, K. R. (2002) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2002.32632 · Cited by 14
Briglia, A., & Anania, F. A. (2002) · Critical Care Clinics · doi:10.1016/s0749-0704(01)00003-3 · Cited by 14
Hypothermia for the management of intracranial hypertension in acute liver failure
Jalan, R., Damink, S. W. M. O., & Deutz, N. E. P. (2003) · Springer eBooks · doi:10.1007/978-94-010-0159-5_40 · Cited by 14
Sørensen, M., Andersen, J. V., Bjerring, P. N., & Vilstrup, H. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01473-x · Cited by 13
Acute Fulminant Hepatic Failure, Encephalopathy and Early CT Changes
Thayapararajah, S. W., Gulka, I. B., Al-Amri, A. H., Das, S., & Young, G. B. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014657 · Cited by 13
“Other causes: alcoholic hepatitis (3), auto-immune hepatitis (1), viral hepatitis (1), multiple toxins (1), valproate-induced hepatic tHe CANADIAN JOURNAL OF NeUROLOGICAL SCIeNCeS”
BackgroundSanyal, A. J., & Stravitz, R. T. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50026-7 · Cited by 13
The mitochondrial permeability transition in ammonia neurotoxicity
Norenberg, M. D., Rao, K. V. R., & Jayakumar, A. R. (2003) · Springer eBooks · doi:10.1007/978-94-010-0159-5_28 · Cited by 15
Neurologic Presentations of Hepatic Disease
Harris, M. K., Elliott, D. G., Schwendimann, R. N., Minagar, A., & Jaffe, S. L. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.09.016 · Cited by 12
Bernal, W. E., & Wendon, J. A. (2000) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200004000-00005 · Cited by 12
Self-citationBrain Edema in Acute Liver Failure
Butterworth, R. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00015-1 · Cited by 12
The Multidisciplinary Pediatric Liver Transplant
Ruan, W. H., Galván, N. T. N., Dike, P. N., Koci, M., Faraone, M., Fuller, K., Koomaraie, S., Cerminara, D. N., Fishman, D. S., Deray, K. G. V., et al. (2023) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2023.101377 · Cited by 12
Acetaminophen Hepatotoxicity: Current Management
Tan, H., Chang, C., & Martin, P. B. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20065 · Cited by 13
Patzer, J. F., López, R., & Aggarwal, S. (2007) · Artificial Organs · doi:10.1111/j.1525-1594.2007.00476.x · Cited by 11
Circulating levels of neuropeptides (cgrp, vip, npy) in patients with fulminant hepatic failure
Strauss, G. I., Edvinsson, L. I., Larsen, F. S., Møller, K., & Knudsen, G. M. (2001) · Neuropeptides · doi:10.1054/npep.2001.0861 · Cited by 10
Brain lactate in hepatic encephalopathy: Friend or foe?
Oria, M., & Jalan, R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.029 · Cited by 11
“[4] Wendon JA, Harrison PM, Keays R, Williams R.”
BackgroundNovel strategies for liver support in acute liver failure
Butler, A. J., & Friend, P. J. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011643 · Cited by 9
Cerebral Blood Flow in Fulminant Hepatitis
Feltracco, P., Serra, E., Barbieri, S., Tiberio, I., Rizzi, S., & Salvaterra, F. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.01.040 · Cited by 8
Bernal, W. E., & Williams, R. L. (2020) · Clinical Liver Disease · doi:10.1002/cld.957 · Cited by 9
Self-citationKurtovic, J., Riordan, S. M., & Williams, R. L. (2005) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-005-0037-5 · Cited by 8
Self-citationNeurocritical Care Management of Hepatic Encephalopathy and Coma in Liver Failure
Kerbert, A. J. C., Engelmann, C., & Jalan, R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1672180 · Cited by 10
“Animal and human studies have shown beneficial effects of treatment with antioxidants in the setting of fulminant liver failure and HE, thereby supporting a role for (ammonia-induced) oxidative stress as a relevant pathomechanism and potential therapeutic target [67-71].”
BackgroundMicrodialysis in the Management of Hepatic Encephalopathy
Hutchinson, P. J., Gimson, A. E., Al-Rawi, P. G., O’Connell, M. T., Czosnyka, M., & Menon, D. K. (2006) · Neurocritical Care · doi:10.1385/ncc:5:3:202 · Cited by 8
“One possibility would be abnormalities of the glucose transporter systems in the brain, but the activity of the astrocyte/endothelial glucose transporter (GLUT-1) is increased, rather than decreased in acute hepatic encephalopathy (22) . Inadequate cerebral blood flow (CBF) seems an equally unlikely explanation, becau…”
BackgroundPathophysiology of Hepatic Encephalopathy: Studies in Animal Models
Butterworth, R. F. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_9 · Cited by 8
Changes in cerebral oxidative metabolism in patients with acute liver failure
Bjerring, P. N., & Larsen, F. S. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9346-2 · Cited by 7
“Yet, in another cohort of ALF patients, brain lactate efflux was found in two thirds of the patients (Wendon et al. 1994).”
BackgroundLockwood, A. H. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50017-1 · Cited by 7
New Directions in Acute Liver Failure
Williams, R. L. (1994) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00701-9 · Cited by 8
Self-citationInterleukin-6 Drives Key Pathologic Outcomes in Experimental Acetaminophen-induced Liver FailurePreprint
Roth, K., Strickland, J. D., Gonzalez-Pons, R., Pant, A., Yen, T.-C., Freeborn, R. A., Kennedy, R., Bhushan, B., Boss, A. P., Rockwell, C. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.15.468664 · Cited by 6
Luis Castillo, F., Cristian Pérez, R., Carolina Ruiz, B., Bugedo, G. J., Glenn Hernández, P., Jorge Martínez, C., Nicolás Jarufe, C., Rosa Pérez, A., Patricio Mellado, T., & Domínguez, P. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000600010 · Cited by 6
‘Fulminant hepatic failure’ anesthesiologic considerations
Vetrugno, L., Alessandri, F., Toscano, A., Voza, A., & Deana, C. (2025) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001530 · Cited by 6
“In an analysis of 116 ALF patients, 11% developed brain death during the perioperative course [29].”
Shang, M., Zhang, Y., Qian, J., Wang, W., Yu, X., Huang, J., Zhou, L., & Zheng, S. (2024) · Nano Research · doi:10.1007/s12274-024-6590-9 · Cited by 7
Acute liver failure and the brain: a look through the crystal ball
Ryan, J. M., Tranah, T. H., Mitry, R. R., Wendon, J. A., & Shawcross, D. L. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9363-1 · Cited by 6
“Early studies on late administration of N-acetylcysteine and intervention studies showed improvement in systemic and cerebral hemodynamics (Harrison et al. 1991; Wendon et al. 1994).”
Self-citationKieslichová, E., Ryska, M., Pantoflíček, T., Ryska, O., Zazula, R., & Skibová, J. (2005) · Physiological Research · doi:10.33549/physiolres.930619 · Cited by 5
“The dose was continuously adjusted according to MAP where every effort was made to maintain MAP for cerebral perfusion pressure to be over 50 mm Hg (Wendon et al. 1994, Blei 1998, Larsen et al. 2000).”
MethodAcute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
Privitera, G., Agarwal, B., & Jalan, R. (2014) · EMJ Hepatology · doi:10.33590/emjhepatol/10313515 · Cited by 5
Ardizzone, G., Arrigo, A., Panaro, F., Centanaro, M., Demartini, M. G., Pellizzari, A., Cifelli, A., Jarzembowski, T. M., Valente, U., & Siani, C. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.05.045 · Cited by 5
Intensive care management of acute liver failure.
Saner, F. H., Kavuk, I., Lang, H., Stavrou, G. A., Paul, A., Doemland, M., Malagó, M., & Broelsch, C. E. (2004) · PubMed · Cited by 5
Liver Transplantation in Patients with Fulminant Hepatitis
Ichaı̈, P., Bismuth, H., & Samuel, D. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50125-3 · Cited by 5
Extracorporeal Treatment in Fulminant Hepatic Failure: Pathophysiologic Considerations
Kramer, L., & Bauer, E. (2002) · The International Journal of Artificial Organs · doi:10.1177/039139880202501006 · Cited by 5
“While some patients may also show a reduction in cerebral blood flow, they appear to be at lower risk of cerebral herniation (25).”
BackgroundNeuroglia in hepatic encephalopathy
Zielińska, M., Popek, M. P., & Albrecht, J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00011-9 · Cited by 4
Karvellas, C. J., Speiser, J. L., Tremblay, M., Lee, W. M., & Rose, C. F. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0323-0 · Cited by 4
Balog, P., Tesch, D., & Poós, A. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33016 · Cited by 4
Maruoka, N., Murata, T., Omata, N., Mitsuya, H., Kiyono, Y., Okazawa, H., & Wada, Y. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0906-8 · Cited by 4
Current management of fulminant hepatic failure
Riordan, S. M., & Williams, R. L. (1999) · Current Opinion in Critical Care · doi:10.1097/00075198-199904000-00008 · Cited by 4
Self-citationNeurologic Consequences of Fulminant Hepatic Failure
Bleck, T. P. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.2.195 · Cited by 4
Henderson, J. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch7h · Cited by 5
Murphy, N., & Wendon, J. A. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch35 · Cited by 4
Self-citationŒdème cérébral et insuffisance hépatique fulminante
Spahr, L. (2003) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(03)00054-6 · Cited by 3
Inamasu, J., Nakamura, Y., Yamamoto, S., Sakamoto, N., Saito, R., Horiguchi, T., & Ichikizaki, K. (2002) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00007-0 · Cited by 3
Pitfalls in intracranial pressure monitoring in fulminant hepatic failure
Larsen, F. S., Ranek, L., & Hansen, B. A. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80073-6 · Cited by 3
Oxidative Stress in Hepatic Encephalopathy
Jayakumar, A. R., & Norenberg, M. D. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-836-8_5 · Cited by 3
Jalan, R., Damink, S. W. M. O., Deutz, N., Redhead, D. N., & Lee, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)80177-5 · Cited by 3
Chang, A. J., Dixit, V., & Saab, S. (2003) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-003-0049-y · Cited by 3
Drug Treatment of Encephalopathy Associated with Fulminant Liver Failure
res, P. T., & Devictor, D. J. (1999) · CNS Drugs · doi:10.2165/00023210-199911050-00002 · Cited by 3
N-acetylcysteine (NAC) treatment of acetaminophen toxicity
Suarez, F., Simon, M. W., & Hoyte, C. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15877-3.00003-x · Cited by 2
Cerebral blood flow physiology, pharmacology, and pathophysiology
Chugh, C., & Kofke, W. A. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198739555.003.0003 · Cited by 2
Is it Worthwhile to Use Cerebral Microdialysis in Patients With Acute Liver Failure?
Larsen, F. S. (2006) · Neurocritical Care · doi:10.1385/ncc:5:3:173 · Cited by 2
Progrès récents dans le traitement des intoxications au paracétamol 2e partie La phase tardive
Jones, A. L., & Lheureux, P. E. R. (1998) · Réanimation Urgences · doi:10.1016/s1164-6756(98)90045-7 · Cited by 2
Jalan, R., Damink, S. W. M. O., Redhead, D. N., Lee, A., Hayes, P. C., & Deutz, N. E. P. (2003) · Springer eBooks · doi:10.1007/978-94-010-0159-5_23 · Cited by 2
Sherlock, F. S., & BSc, J. D. (2001) · doi:10.1002/9780470986820.ch8 · Cited by 2
Tikhonova, L. A., Maevsky, E. I., Montoliú, C., & Kosenko, E. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156739 · Cited by 1
“However, due to the activation of various endogenous autoregulatory factors in each specific case [18,19], the final results of the measurement of these indicators can be ambiguous [20].”
Oxidative Stress in the Central Nervous System Complications of Chronic Liver Failure
Bémeur, C. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-15539-5_16 · Cited by 1
Acute Liver Failure: Perioperative Management
Aggarwal, S., Mazariegos, G. V., & Blisard, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6377-5_32 · Cited by 1
Koch, A. H., & Trautwein, C. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-009-0153-x · Cited by 1
Acute Hepatic Failure in the ACS Patient: Nuts and Bolts of Pathophysiology and Therapy
PEREIRA, B. M. T. (2019) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-11830-3_8 · Cited by 1
Management of Hepatic Encephalopathy in the Neurocritical Care Unit
Riordan, S. M., & Williams, R. L. (2019) · Cambridge University Press eBooks · doi:10.1017/9781107587908.030 · Cited by 1
Self-citationRiordan, S. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_64 · Cited by 1
Controversies in Managing Children with Fulminant Liver Failure
Devictor, D. J., Yandza, T., & Soubrane, O. (1995) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-642-79154-3_67 · Cited by 1
The Pathology and Management of Intracranial Hypertension in Acute Liver Failure
Murphy, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-49518-7_60 · Cited by 1
“This suggestion is supported by an increase in extracellular lactate and brain lactate flux seen in clinical studies [19, 20].”
BackgroundAdjunct drugs in liver transplantation
Vater, Y., Dembo, G. A., Levy, A. E., Hunter, C., & Martay, K. (2002) · Seminars in Anesthesia Perioperative Medicine and Pain · doi:10.1053/sane.2002.34196 · Cited by 1
Treatment of Fulminant Hepatic Failure – Is There Light at the End of the Tunnel?
Kaita, K. D. E. (1995) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1995/847146 · Cited by 1
“Furthermore, N-acetylcysteine improves cerebral bloodflow and cerebral metabolic rate for oxygen which, in turn, may account for the reduced incidence of cerebral edema in patients suffering from FHF treated with late N-acetylcysteine (95).”
BackgroundInfluentialSuk, E. H., Cho, I. S., Hwang, K. S., & Choi, K. T. (2002) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2002.43.2.165 · Cited by 1
The management of acute liver failure
Jackson, N. W., & Wendon, J. A. (2000) · Clinical Intensive Care · doi:10.1080/714028696 · Cited by 1
Self-citationDiagnosis and Management of Liver Failure in the Adult
Murphy, N. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50078-9 · Cited by 2
Larson, A. M. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch19 · Cited by 1
Butterworth, R. F., & Vaquero, J. (2009) · doi:10.1002/9780470747919.ch39 · Cited by 1
Holt, A. W. (1999) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00645-2 · Cited by 4
“The most recent data from the King’s group shows that 73% of patients with grade IV encephalopathy have a low CBF and that all patients who were studied had a low cerebral metabolic rate for oxygen.(12) This reduced oxygen consumption was associated with evidence of”
BackgroundProgrès récents dans le traitement des intoxications au paracétamol: 1ère partie: La phase précoce
Jones, A. L., & Lheureux, P. E. R. (1998) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Fulminant Hepatic Failure: Treatment
O’Beirne, J. P., Murphy, N., & Wendon, J. A. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch41
Self-citationCerebral oedema in acute liver failure
Keays, R. T. (1998) · Current Anaesthesia and Critical Care · doi:10.1016/s0953-7112(98)80055-0
Self-citationPrise en charge des hépatites fulminantes
Ichaï, P. (2009) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2009.07.005 · Cited by 1
Analytic Reviews : Management of Acetaminophen Toxicity in the Intensive Care Unit
Kuffner, E. K., Heard, K. J., & O’Malley, G. F. (1999) · Journal of Intensive Care Medicine · doi:10.1177/088506669901400401
Metadata
- Authors
- Wendon, J. A., Harrison, P. M., Keays, R., & Williams, R.
- Affiliations
- King's College London (GB)
- Corresponding author
- Williams, Roger
- Venue
- Hepatology
- Published
- 1994-06
- Volume
- 19
- Issue
- 6
- Pages
- 1407-1413
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2160749102
- Cited by
- 220
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 1 · 2014: 3 · 2013: 5 · 2012: 9
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7762 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- acute liver failure, cerebral blood flow, cerebral oxygen consumption, hepatic encephalopathy, cerebral edema, intracranial pressure, hyperventilation, mannitol, N-acetylcysteine, epoprostenol, prostacyclin, cerebral ischemia
- MeSH terms
- Acetaminophen, Acetylcysteine, Adult, Blood Flow Velocity, Brain, Brain Edema, Female, Glucose, Hepatic Encephalopathy, Hepatitis, Viral, Human, Humans, Lactates, Male, Mannitol, Middle Aged, Oxygen, Epoprostenol, Regional Blood Flow, Respiration, Artificial, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.